Marc R. Mcclelland

Marc R. Mcclelland

Pulmonary Medicine | Intensive Care Medicine

35 Michigan Street Northeast
Suite 3003/4150
Grand Rapids, MI 49503

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 7 publications

Linking volatile metabolites from bacterial pathogens to exhaled breath condensate of people with cystic fibrosis.

Linking volatile metabolites from bacterial pathogens to exhaled breath condensate of people with cystic fibrosis.

Journal: Microbiology (Reading, England)

Published: February 20, 2025

Microenvironmental effects of a non-antibiotic therapy for a chronic Polymicrobial infection Alter microbial physiology, competition, and virulence.

Microenvironmental effects of a non-antibiotic therapy for a chronic Polymicrobial infection Alter microbial physiology, competition, and virulence.

Journal: The ISME journal

Published: February 07, 2025

Longitudinal microbial and molecular dynamics in the cystic fibrosis lung after Elexacaftor-Tezacaftor-Ivacaftor therapy.

Longitudinal microbial and molecular dynamics in the cystic fibrosis lung after Elexacaftor-Tezacaftor-Ivacaftor therapy.

Journal: Respiratory research

Published: October 18, 2023

Longitudinal Microbial and Molecular Dynamics in the Cystic Fibrosis Lung after Elexacaftor-Tezacaftor-Ivacaftor therapy.

Longitudinal Microbial and Molecular Dynamics in the Cystic Fibrosis Lung after Elexacaftor-Tezacaftor-Ivacaftor therapy.

Journal: Research square

Published: October 16, 2023

Complex and unexpected outcomes of antibiotic therapy against a polymicrobial infection.

Complex and unexpected outcomes of antibiotic therapy against a polymicrobial infection.

Journal: The ISME journal

Published: February 10, 2022

A restructuring of microbiome niche space is associated with Elexacaftor-Tezacaftor-Ivacaftor therapy in the cystic fibrosis lung.

A restructuring of microbiome niche space is associated with Elexacaftor-Tezacaftor-Ivacaftor therapy in the cystic fibrosis lung.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: July 26, 2021

Bronchial Thermoplasty in Patients With Severe Asthma at 5 Years: The Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma Study.

Bronchial Thermoplasty in Patients With Severe Asthma at 5 Years: The Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma Study.

Journal: Chest

Published: June 23, 2021

Showing 1-7 of 7

Last Updated: 09/26/2026